A Study to Evaluate the Efficacy and Safety of CnU Capsule 750 mg in Patients With Cholesterol Gallstones(GB Stones).
Clinical trial NCT07005752 · RECRUITING
Trial details
- NCT number
- NCT07005752
- Sponsor
- Myungmoon Pharma. Co. Ltd.
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-28
- Primary completion
- 2027-11-10
- Enrollment
- 484
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.